Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection

Identifieur interne : 000893 ( PascalFrancis/Checkpoint ); précédent : 000892; suivant : 000894

Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection

Auteurs : WEIJUN CHEN [République populaire de Chine] ; ZUYUAN XU [République populaire de Chine] ; JINGSONG MU [République populaire de Chine] ; LING YANG [République populaire de Chine] ; HAIXUE GAN [République populaire de Chine] ; FENG MU [République populaire de Chine] ; BAOXING FAN [République populaire de Chine] ; BO HE [République populaire de Chine] ; SHENGYONG HUANG [République populaire de Chine] ; BO YOU [République populaire de Chine] ; YONGKUI YANG [République populaire de Chine] ; XIANGJUN TANG [République populaire de Chine] ; LING QIU [République populaire de Chine] ; YAN QIU [République populaire de Chine] ; JIE WEN [République populaire de Chine] ; JIANQIU FANG [République populaire de Chine] ; JIAN WANG [République populaire de Chine]

Source :

RBID : Pascal:04-0283140

Descripteurs français

English descriptors

Abstract

To understand the time-course of viraemia and antibody responses to severe acute respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used to assay 376 blood samples from 135 SARS patients at various stages of the illness, including samples from patients who were in their early convalescent phase. The results showed that IgM antibodies decreased and became undetectable 11 weeks into the recovery phase. IgG antibodies, however, remained detectable for a period beyond 11 weeks and were found in 100 % of patients in the early convalescent phase. SARS-CoV viraemia mainly appeared 1 week after the onset of illness and then decreased over a period of 1 month, becoming undetectable in the blood samples of the convalescent patients. At the peak of viraemia, viral RNA was detectable in 75 % of blood samples from patients who were clinically diagnosed with SARS 1 or 2 weeks before the test.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:04-0283140

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection</title>
<author>
<name sortKey="Weijun Chen" sort="Weijun Chen" uniqKey="Weijun Chen" last="Weijun Chen">WEIJUN CHEN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zuyuan Xu" sort="Zuyuan Xu" uniqKey="Zuyuan Xu" last="Zuyuan Xu">ZUYUAN XU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Institute of Genetics and Developmental Biology, Chinese Academy of Sciences</s1>
<s2>Beijing 100101</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jingsong Mu" sort="Jingsong Mu" uniqKey="Jingsong Mu" last="Jingsong Mu">JINGSONG MU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Beijing 302 Hospital</s1>
<s2>Beijing 100039</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ling Yang" sort="Ling Yang" uniqKey="Ling Yang" last="Ling Yang">LING YANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Haixue Gan" sort="Haixue Gan" uniqKey="Haixue Gan" last="Haixue Gan">HAIXUE GAN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Feng Mu" sort="Feng Mu" uniqKey="Feng Mu" last="Feng Mu">FENG MU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Baoxing Fan" sort="Baoxing Fan" uniqKey="Baoxing Fan" last="Baoxing Fan">BAOXING FAN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Beijing 301 Hospital</s1>
<s2>Beijing 100853</s2>
<s3>CHN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bo He" sort="Bo He" uniqKey="Bo He" last="Bo He">BO HE</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shengyong Huang" sort="Shengyong Huang" uniqKey="Shengyong Huang" last="Shengyong Huang">SHENGYONG HUANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bo You" sort="Bo You" uniqKey="Bo You" last="Bo You">BO YOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yongkui Yang" sort="Yongkui Yang" uniqKey="Yongkui Yang" last="Yongkui Yang">YONGKUI YANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xiangjun Tang" sort="Xiangjun Tang" uniqKey="Xiangjun Tang" last="Xiangjun Tang">XIANGJUN TANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ling Qiu" sort="Ling Qiu" uniqKey="Ling Qiu" last="Ling Qiu">LING QIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Beijing Union Hospital</s1>
<s2>Beijing 100730</s2>
<s3>CHN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yan Qiu" sort="Yan Qiu" uniqKey="Yan Qiu" last="Yan Qiu">YAN QIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Beijing Red Cross Blood Center</s1>
<s2>Beijing 100088</s2>
<s3>CHN</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jie Wen" sort="Jie Wen" uniqKey="Jie Wen" last="Jie Wen">JIE WEN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jianqiu Fang" sort="Jianqiu Fang" uniqKey="Jianqiu Fang" last="Jianqiu Fang">JIANQIU FANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jian Wang" sort="Jian Wang" uniqKey="Jian Wang" last="Jian Wang">JIAN WANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">04-0283140</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0283140 INIST</idno>
<idno type="RBID">Pascal:04-0283140</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000896</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000094</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000893</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000893</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection</title>
<author>
<name sortKey="Weijun Chen" sort="Weijun Chen" uniqKey="Weijun Chen" last="Weijun Chen">WEIJUN CHEN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zuyuan Xu" sort="Zuyuan Xu" uniqKey="Zuyuan Xu" last="Zuyuan Xu">ZUYUAN XU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Institute of Genetics and Developmental Biology, Chinese Academy of Sciences</s1>
<s2>Beijing 100101</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jingsong Mu" sort="Jingsong Mu" uniqKey="Jingsong Mu" last="Jingsong Mu">JINGSONG MU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Beijing 302 Hospital</s1>
<s2>Beijing 100039</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ling Yang" sort="Ling Yang" uniqKey="Ling Yang" last="Ling Yang">LING YANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Haixue Gan" sort="Haixue Gan" uniqKey="Haixue Gan" last="Haixue Gan">HAIXUE GAN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Feng Mu" sort="Feng Mu" uniqKey="Feng Mu" last="Feng Mu">FENG MU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Baoxing Fan" sort="Baoxing Fan" uniqKey="Baoxing Fan" last="Baoxing Fan">BAOXING FAN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Beijing 301 Hospital</s1>
<s2>Beijing 100853</s2>
<s3>CHN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bo He" sort="Bo He" uniqKey="Bo He" last="Bo He">BO HE</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shengyong Huang" sort="Shengyong Huang" uniqKey="Shengyong Huang" last="Shengyong Huang">SHENGYONG HUANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bo You" sort="Bo You" uniqKey="Bo You" last="Bo You">BO YOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yongkui Yang" sort="Yongkui Yang" uniqKey="Yongkui Yang" last="Yongkui Yang">YONGKUI YANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xiangjun Tang" sort="Xiangjun Tang" uniqKey="Xiangjun Tang" last="Xiangjun Tang">XIANGJUN TANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ling Qiu" sort="Ling Qiu" uniqKey="Ling Qiu" last="Ling Qiu">LING QIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Beijing Union Hospital</s1>
<s2>Beijing 100730</s2>
<s3>CHN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Yan Qiu" sort="Yan Qiu" uniqKey="Yan Qiu" last="Yan Qiu">YAN QIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Beijing Red Cross Blood Center</s1>
<s2>Beijing 100088</s2>
<s3>CHN</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jie Wen" sort="Jie Wen" uniqKey="Jie Wen" last="Jie Wen">JIE WEN</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jianqiu Fang" sort="Jianqiu Fang" uniqKey="Jianqiu Fang" last="Jianqiu Fang">JIANQIU FANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jian Wang" sort="Jian Wang" uniqKey="Jian Wang" last="Jian Wang">JIAN WANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of medical microbiology</title>
<title level="j" type="abbreviated">J. med. microbiol.</title>
<idno type="ISSN">0022-2615</idno>
<imprint>
<date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of medical microbiology</title>
<title level="j" type="abbreviated">J. med. microbiol.</title>
<idno type="ISSN">0022-2615</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibody</term>
<term>Coronavirus</term>
<term>Microbiology</term>
<term>Severe acute respiratory syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Coronavirus</term>
<term>Anticorps</term>
<term>Microbiologie</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To understand the time-course of viraemia and antibody responses to severe acute respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used to assay 376 blood samples from 135 SARS patients at various stages of the illness, including samples from patients who were in their early convalescent phase. The results showed that IgM antibodies decreased and became undetectable 11 weeks into the recovery phase. IgG antibodies, however, remained detectable for a period beyond 11 weeks and were found in 100 % of patients in the early convalescent phase. SARS-CoV viraemia mainly appeared 1 week after the onset of illness and then decreased over a period of 1 month, becoming undetectable in the blood samples of the convalescent patients. At the peak of viraemia, viral RNA was detectable in 75 % of blood samples from patients who were clinically diagnosed with SARS 1 or 2 weeks before the test.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0022-2615</s0>
</fA01>
<fA02 i1="01">
<s0>JMMIAV</s0>
</fA02>
<fA03 i2="1">
<s0>J. med. microbiol.</s0>
</fA03>
<fA05>
<s2>53</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>WEIJUN CHEN</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>ZUYUAN XU</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>JINGSONG MU</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>LING YANG</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>HAIXUE GAN</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>FENG MU</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BAOXING FAN</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>BO HE</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>SHENGYONG HUANG</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>BO YOU</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>YONGKUI YANG</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>XIANGJUN TANG</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>LING QIU</s1>
</fA11>
<fA11 i1="14" i2="1">
<s1>YAN QIU</s1>
</fA11>
<fA11 i1="15" i2="1">
<s1>JIE WEN</s1>
</fA11>
<fA11 i1="16" i2="1">
<s1>JIANQIU FANG</s1>
</fA11>
<fA11 i1="17" i2="1">
<s1>JIAN WANG</s1>
</fA11>
<fA14 i1="01">
<s1>Beijing Genomics Institute, Chinese Academy of Sciences</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Beijing BGI-GBI Biotech Co. Ltd</s1>
<s2>Beijing 101300</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>15 aut.</sZ>
<sZ>16 aut.</sZ>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Institute of Genetics and Developmental Biology, Chinese Academy of Sciences</s1>
<s2>Beijing 100101</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Beijing 302 Hospital</s1>
<s2>Beijing 100039</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Beijing 301 Hospital</s1>
<s2>Beijing 100853</s2>
<s3>CHN</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Beijing Union Hospital</s1>
<s2>Beijing 100730</s2>
<s3>CHN</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Beijing Red Cross Blood Center</s1>
<s2>Beijing 100088</s2>
<s3>CHN</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA20>
<s1>435-438</s1>
</fA20>
<fA21>
<s1>2004</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>988B</s2>
<s5>354000111948760130</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>17 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>04-0283140</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of medical microbiology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>To understand the time-course of viraemia and antibody responses to severe acute respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used to assay 376 blood samples from 135 SARS patients at various stages of the illness, including samples from patients who were in their early convalescent phase. The results showed that IgM antibodies decreased and became undetectable 11 weeks into the recovery phase. IgG antibodies, however, remained detectable for a period beyond 11 weeks and were found in 100 % of patients in the early convalescent phase. SARS-CoV viraemia mainly appeared 1 week after the onset of illness and then decreased over a period of 1 month, becoming undetectable in the blood samples of the convalescent patients. At the peak of viraemia, viral RNA was detectable in 75 % of blood samples from patients who were clinically diagnosed with SARS 1 or 2 weeks before the test.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A05C10</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Anticorps</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Antibody</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Anticuerpo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Microbiologie</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Microbiology</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Microbiología</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Syndrome respiratoire aigu sévère</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Síndrome respiratorio agudo severo</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Appareil respiratoire pathologie</s0>
<s5>19</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Respiratory disease</s0>
<s5>19</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Aparato respiratorio patología</s0>
<s5>19</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Poumon pathologie</s0>
<s5>20</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Lung disease</s0>
<s5>20</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Pulmón patología</s0>
<s5>20</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Virose</s0>
<s2>NM</s2>
<s5>21</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Viral disease</s0>
<s2>NM</s2>
<s5>21</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Virosis</s0>
<s2>NM</s2>
<s5>21</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Infection</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Infection</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Infección</s0>
<s2>NM</s2>
</fC07>
<fN21>
<s1>173</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Pékin</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Weijun Chen" sort="Weijun Chen" uniqKey="Weijun Chen" last="Weijun Chen">WEIJUN CHEN</name>
</noRegion>
<name sortKey="Baoxing Fan" sort="Baoxing Fan" uniqKey="Baoxing Fan" last="Baoxing Fan">BAOXING FAN</name>
<name sortKey="Bo He" sort="Bo He" uniqKey="Bo He" last="Bo He">BO HE</name>
<name sortKey="Bo You" sort="Bo You" uniqKey="Bo You" last="Bo You">BO YOU</name>
<name sortKey="Feng Mu" sort="Feng Mu" uniqKey="Feng Mu" last="Feng Mu">FENG MU</name>
<name sortKey="Feng Mu" sort="Feng Mu" uniqKey="Feng Mu" last="Feng Mu">FENG MU</name>
<name sortKey="Haixue Gan" sort="Haixue Gan" uniqKey="Haixue Gan" last="Haixue Gan">HAIXUE GAN</name>
<name sortKey="Jian Wang" sort="Jian Wang" uniqKey="Jian Wang" last="Jian Wang">JIAN WANG</name>
<name sortKey="Jian Wang" sort="Jian Wang" uniqKey="Jian Wang" last="Jian Wang">JIAN WANG</name>
<name sortKey="Jianqiu Fang" sort="Jianqiu Fang" uniqKey="Jianqiu Fang" last="Jianqiu Fang">JIANQIU FANG</name>
<name sortKey="Jianqiu Fang" sort="Jianqiu Fang" uniqKey="Jianqiu Fang" last="Jianqiu Fang">JIANQIU FANG</name>
<name sortKey="Jie Wen" sort="Jie Wen" uniqKey="Jie Wen" last="Jie Wen">JIE WEN</name>
<name sortKey="Jie Wen" sort="Jie Wen" uniqKey="Jie Wen" last="Jie Wen">JIE WEN</name>
<name sortKey="Jingsong Mu" sort="Jingsong Mu" uniqKey="Jingsong Mu" last="Jingsong Mu">JINGSONG MU</name>
<name sortKey="Ling Qiu" sort="Ling Qiu" uniqKey="Ling Qiu" last="Ling Qiu">LING QIU</name>
<name sortKey="Ling Yang" sort="Ling Yang" uniqKey="Ling Yang" last="Ling Yang">LING YANG</name>
<name sortKey="Ling Yang" sort="Ling Yang" uniqKey="Ling Yang" last="Ling Yang">LING YANG</name>
<name sortKey="Shengyong Huang" sort="Shengyong Huang" uniqKey="Shengyong Huang" last="Shengyong Huang">SHENGYONG HUANG</name>
<name sortKey="Weijun Chen" sort="Weijun Chen" uniqKey="Weijun Chen" last="Weijun Chen">WEIJUN CHEN</name>
<name sortKey="Xiangjun Tang" sort="Xiangjun Tang" uniqKey="Xiangjun Tang" last="Xiangjun Tang">XIANGJUN TANG</name>
<name sortKey="Yan Qiu" sort="Yan Qiu" uniqKey="Yan Qiu" last="Yan Qiu">YAN QIU</name>
<name sortKey="Yongkui Yang" sort="Yongkui Yang" uniqKey="Yongkui Yang" last="Yongkui Yang">YONGKUI YANG</name>
<name sortKey="Zuyuan Xu" sort="Zuyuan Xu" uniqKey="Zuyuan Xu" last="Zuyuan Xu">ZUYUAN XU</name>
<name sortKey="Zuyuan Xu" sort="Zuyuan Xu" uniqKey="Zuyuan Xu" last="Zuyuan Xu">ZUYUAN XU</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000893 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000893 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:04-0283140
   |texte=   Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021